| Dr Erin Ducharme, MD | |
|
16349 Sheridan Drive, Suite 101, Clive, IA 50325 | |
| (515) 987-0333 | |
| (833) 288-7944 |
| Full Name | Dr Erin Ducharme |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 17 Years |
| Location | 16349 Sheridan Drive, Clive, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891961900 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MD-40967 (Iowa) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ducharme Dermatology Pc | 1254689268 | 2 |
News Archive
Novo Nordisk announced today that a Biologic License Application has been submitted to the U.S. Food and Drug Administration requesting the approval of a recombinant factor XIII compound for the vast majority of patients with congenital factor XIII deficiency, an inherited bleeding disorder.
The Food and Drug Administration (FDA) today approved Taxotere (docetaxel) Injection Concentrate for use in combination with cisplatin and fluorouracil prior to radiotherapy for the treatment of patients with inoperable, locally advanced squamous cell carcinoma of the head and neck (SCCHN).
"As the debate over federal budget allocations and cuts continues, the National Institutes of Health, a leading funder for both domestic and global health research, could experience a whopping $1 billion budget cut," Karen Siegel and colleagues from Emory University write in the Health Affairs Blog.
Sleep has been underrated as the best medicine to fight off disease say researchers working on a new study. The study titled, "Gαs-Coupled Receptor Signaling and Sleep Regulate Integrin Activation of Human Antigen-Specific T Cells," was published this week in the Journal of Experimental Medicine.
› Verified 4 days ago
| Entity Name | Ducharme Dermatology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891214896 PECOS PAC ID: 1254689268 Enrollment ID: O20180808001651 |
News Archive
Novo Nordisk announced today that a Biologic License Application has been submitted to the U.S. Food and Drug Administration requesting the approval of a recombinant factor XIII compound for the vast majority of patients with congenital factor XIII deficiency, an inherited bleeding disorder.
The Food and Drug Administration (FDA) today approved Taxotere (docetaxel) Injection Concentrate for use in combination with cisplatin and fluorouracil prior to radiotherapy for the treatment of patients with inoperable, locally advanced squamous cell carcinoma of the head and neck (SCCHN).
"As the debate over federal budget allocations and cuts continues, the National Institutes of Health, a leading funder for both domestic and global health research, could experience a whopping $1 billion budget cut," Karen Siegel and colleagues from Emory University write in the Health Affairs Blog.
Sleep has been underrated as the best medicine to fight off disease say researchers working on a new study. The study titled, "Gαs-Coupled Receptor Signaling and Sleep Regulate Integrin Activation of Human Antigen-Specific T Cells," was published this week in the Journal of Experimental Medicine.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Erin Ducharme, MD 16349 Sheridan Ave Ste 101, Clive, IA 50325-4675 Ph: (515) 987-0333 | Dr Erin Ducharme, MD 16349 Sheridan Drive, Suite 101, Clive, IA 50325 Ph: (515) 987-0333 |
News Archive
Novo Nordisk announced today that a Biologic License Application has been submitted to the U.S. Food and Drug Administration requesting the approval of a recombinant factor XIII compound for the vast majority of patients with congenital factor XIII deficiency, an inherited bleeding disorder.
The Food and Drug Administration (FDA) today approved Taxotere (docetaxel) Injection Concentrate for use in combination with cisplatin and fluorouracil prior to radiotherapy for the treatment of patients with inoperable, locally advanced squamous cell carcinoma of the head and neck (SCCHN).
"As the debate over federal budget allocations and cuts continues, the National Institutes of Health, a leading funder for both domestic and global health research, could experience a whopping $1 billion budget cut," Karen Siegel and colleagues from Emory University write in the Health Affairs Blog.
Sleep has been underrated as the best medicine to fight off disease say researchers working on a new study. The study titled, "Gαs-Coupled Receptor Signaling and Sleep Regulate Integrin Activation of Human Antigen-Specific T Cells," was published this week in the Journal of Experimental Medicine.
› Verified 4 days ago
Imge Hulur, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 12327 Stratford Dr, Clive, IA 50325 Phone: 515-224-7088 Fax: 515-224-9228 | |
Dr. Vincent Louis Angeloni, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 12327 Stratford Dr, Clive, IA 50325 Phone: 515-224-7088 Fax: 515-224-9228 | |
Dr. Steven Lee Harlan, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8131 University Blvd, Clive, IA 50325 Phone: 515-225-8180 Fax: 515-225-2041 | |
Dr. Ava Risa Feldman, D.O. Dermatology Medicare: Medicare Enrolled Practice Location: 12327 Stratford Dr, Clive, IA 50325 Phone: 515-224-7088 Fax: 515-224-9228 |